Dr. Yao Wang, MD

Dr. Wang practices at Eyesthetica in Los Angeles, California.

Dr. Wang's NPI, 1073933545, was assigned on April 23, 2014. Dr. Wang graduated from University Of Michigan Medical School in 2014. Dr. Wang holds California license A161002.

Dr. Wang's primary practice is Eyesthetica, at 500 S Molino St, Los Angeles, CA 90013 in Los Angeles County. The practice phone is (213) 234-1000.

Dr. Wang's primary practice is Eyesthetica in Los Angeles, California. Dmand AI also links Dr. Wang to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Wang is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Wang's licenses on file in 2 states: California and Minnesota.

Dmand AI lists conjunctivitis, dry eye, eyelid inflammation and visual impairment and blindness among the conditions Dr. Wang treats.

CMS data shows 1,272 Medicare services from Dr. Wang across 14 procedure codes in 2024, for 326 Medicare patients. Medicare paid $133,574 for them.

CMS counts 326 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 142 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 61, with 65% women.

In 2024, Dr. Wang wrote 617 Medicare Part D claims for 274 patients. 79% of them were for generic drugs. CMS names the drug for 530 of them, across 5 drugs with 11 or more claims each, at $8,335 in total drug cost. In 2023, CMS named 555 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of melanoma (skin cancer) excision by Dr. Wang, more than 69% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 299 papers to Dr. Wang, published from 2010 to 2025. 2024 was the busiest year, with 34. The most frequent topics are Graves Ophthalmopathy, Mice, Knockout and Breast Neoplasms. Dr. Wang has published most often in Nat Commun. Dr. Wang's most frequent co-authors are Raymond S. Douglas, MD, PhD, Deborah M. Axelrod, MD and Michael S. Lee, MD.

CMS Open Payments shows 13 general payments to Dr. Wang from 4 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 41% of the total. Horizon Pharma plc paid the most, $1,656.

Dr. Wang graduated from University Of Michigan Medical School in 2014.

Dr. Wang is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.